Table 3.
Multiple linear regressions of Gd-IgA1 (mg/dL) on age, sex, race, MAP, eGFR, urinary protein level, and antihypertensive medication use (n = 123; consists of only patients with IgAN)
| Independent variable | Regression coefficient (95% confidence interval) | p value |
|---|---|---|
| Age (years) | 0.012 (−0.001 to 0.025) | 0.073 |
| Male (Ref: female) | 0.127 (−0.170 to 0.423) | 0.399 |
| Greek (Ref: Japanese) | 0.544 (0.232 to 0.857) | 0.001 |
| MAP (mmHg) | 0.007 (−0.007 to 0.020) | 0.329 |
| eGFR (ml/min/1.73 m2) | 0.004 (−0.003 to 0.011) | 0.239 |
| Urinary protein (g/gCr) | 0.000 (−0.071 to 0.071) | 0.994 |
| Antihypertensive medication use, yes (Ref: no) | 0.158 (−0.162 to 0.477) | 0.331 |
Gd-IgA1, galactose-deficient IgA1; IgAN, IgA nephropathy; HC, healthy control; MAP, mean arterial pressure; eGFR, estimated glomerular filtration rate.